Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by

Abstract

Insights

Blocking the janus-activated kinase (JAK) pathway reduces tumor necrosis factor-α (TNF)-induced interleukin-18 (IL-18) bioactivity by inhibiting caspase-1. This suggests JAK inhibition is a potential therapeutic strategy for rheumatoid arthritis (RA).

Area of Science:

  • Immunology and Inflammation Research
  • Molecular Biology and Signaling Pathways

Background:

  • Tumor necrosis factor-α (TNF) plays a key role in the inflammatory processes of rheumatoid arthritis (RA).
  • Interleukin-18 (IL-18) is a pro-inflammatory cytokine implicated in RA pathogenesis.
  • The janus-activated kinase (JAK) pathway is a critical signaling cascade involved in immune responses.

Purpose of the Study:

  • To investigate the role of the JAK pathway in modulating TNF-induced IL-18 bioactivity.
  • To examine the impact of reducing caspase-1 function on TNF-induced IL-18 bioactivity.
  • To explore the potential of JAK inhibition as a therapeutic approach for RA.

Main Methods:

  • Caspase-1 expression in RA synovial fibroblasts stimulated with TNF was analyzed using qRT-PCR and Western blot.
  • IL-18 levels and bioactivity were assessed via ELISA, immunofluorescence (IF), and functional assays with KG-1 cells.
  • The involvement of JAK and ERK1/2 pathways was determined using chemical signaling inhibitors.

Main Results:

  • TNF significantly increased caspase-1 expression in RA synovial fibroblasts at the protein level.
  • Inhibition of the JAK pathway markedly reduced TNF-induced caspase-1 expression (transcriptional and protein levels) and IL-18 bioactivity.
  • Blocking the JAK pathway led to intracytoplasmic granular IL-18 expression, indicating impaired caspase-1 processing.

Conclusions:

  • The JAK pathway is crucial for regulating TNF-induced IL-18 bioactivity in RA synovial fibroblasts.
  • Inhibition of caspase-1, modulated by JAK signaling, offers a novel mechanism to control IL-18 bioactivity.
  • JAK inhibition presents a promising therapeutic avenue for managing rheumatoid arthritis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
8.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K